Be specific and provide relevant information about BSGM.US. Company Performance: Better-than-expected earnings reports, revenue growth, or positive clinical trial results for BioSig Technologies (BSGM) typically drive the stock price up. Conversely, disappointing results or regulatory setbacks can cause the price to fall. Industry Trends: Positive developments in the electrophysiology (EP) market, particularly related to BSGM's PURE EP system, can boost investor confidence. Conversely, increased competition or unfavorable regulatory changes in the medical device industry could negatively affect the stock. Market Sentiment: Overall market conditions and investor risk appetite influence BSGM.US. A bull market often lifts smaller, speculative stocks like BSGM, while a bear market can depress them. Regulatory Approvals: FDA approvals or clearances for BSGM's devices, especially PURE EP, are major catalysts for price increases. Delays or denials of approvals can significantly lower the stock price. Partnerships and Acquisitions: Collaborations with major medical device companies or potential acquisition offers often result in a surge in BSGM's stock price. Lack of partnerships or failed acquisition attempts can have the opposite effect. Cash Runway: BSGM's financial health, particularly its cash runway, is a key factor. A strong cash position reassures investors, while concerns about needing to raise more capital through dilution can pressure the stock. Technological Advancements: Breakthroughs in BSGM's technology, such as improvements to the PURE EP system, can attract investors and increase the stock price. Stagnation or competitive innovations could have a negative impact. Analyst Ratings: Positive ratings from financial analysts can increase investor confidence and drive up demand for BSGM shares. Downgrades can lead to selling pressure.